Chun-Han Chen

发表

Cancer Therapy : Preclinical Synergistic Interaction between the HDAC Inhibitor , MPT 0 E 028 , and Sorafenib in Liver Cancer Cells In Vitro and In Vivo

C. Chen, C. Teng, S. Pan, 2014 .

Synergistic Interaction between the HDAC Inhibitor, MPT0E028, and Sorafenib in Liver Cancer Cells In Vitro and In Vivo

C. Chen, C. Teng, S. Pan, 2014, Clinical Cancer Research.

Abemaciclib, A Selective CDK4/6 Inhibitor, Restricts the Growth of Pediatric Ependymomas

Tsung-Han Hsieh, Yun-Ru Liu, Yu-chen Lin, 2020, Cancers.

α-Tomatine-Mediated Anti-Cancer Activity In Vitro and In Vivo through Cell Cycle- and Caspase-Independent Pathways

C. Teng, S. Pan, Ya-Ling Chang, 2012, PLoS ONE.

The Novel Reductase Inhibitor COH29 Inhibits DNA Repair In Vitro.

Yate-Ching Yuan, Y. Yen, Xiyong Liu, 2015 .

Integrin β3 and LKB1 are independently involved in the inhibition of proliferation by lovastatin in human intrahepatic cholangiocarcinoma

Y. Yen, Yun-Ru Liu, Hung-Yun Lin, 2015, Oncotarget.

Protopine, a novel microtubule-stabilizing agent, causes mitotic arrest and apoptotic cell death in human hormone-refractory prostate cancer cell lines.

C. Teng, S. Pan, J. Guh, 2012, Cancer letters.

Histone Deacetylase Inhibitors Stimulate Histone H3 Lysine 4 Methylation in Part Via Transcriptional Repression of Histone H3 Lysine 4 Demethylases

J. Byrd, S. Kulp, C. Teng, 2011, Molecular Pharmacology.

Energy Restriction-mimetic Agents Induce Apoptosis in Prostate Cancer Cells in Part through Epigenetic Activation of KLF6 Tumor Suppressor Gene Expression*

S. Kulp, Dasheng Wang, Qianben Wang, 2011, The Journal of Biological Chemistry.

Targeting Autophagy by MPT0L145, a Highly Potent PIK3C3 Inhibitor, Provides Synergistic Interaction to Targeted or Chemotherapeutic Agents in Cancer Cells

Y. Yen, Tsung-Han Hsieh, Yun-Ru Liu, 2019, Cancers.

Design, synthesis, and evaluation of N-phenyl-4-(2-phenylsulfonamido)-benzamides as microtubule-targeting agents in drug-resistant cancer cells, displaying HDAC inhibitory response.

J. Liou, Wei-Cheng Wu, Mei-Hsiang Lin, 2020, European journal of medicinal chemistry.

Thrombin induces expression of twist and cell motility via the hypoxia‐inducible factor‐1α translational pathway in colorectal cancer cells

C. Teng, S. Pan, Hui-Chen Pai, 2011, Journal of cellular physiology.

MPT0G612, a Novel HDAC6 Inhibitor, Induces Apoptosis and Suppresses IFN-γ-Induced Programmed Death-Ligand 1 in Human Colorectal Carcinoma Cells

Yu-chen Lin, J. Liou, Chun-Han Chen, 2019, Cancers.

Novel oral histone deacetylase inhibitor, MPT0E028, displays potent growth-inhibitory activity against human B-cell lymphoma in vitro and in vivo

C. Teng, S. Pan, Chieh-Yu Peng, 2014, Oncotarget.

The Novel Ribonucleotide Reductase Inhibitor COH29 Inhibits DNA Repair In Vitro

Yate-Ching Yuan, Y. Yen, Xiyong Liu, 2015, Molecular Pharmacology.

Trichlorobenzene-substituted azaaryl compounds as novel FGFR inhibitors exhibiting potent antitumor activity in bladder cancer cells in vitro and in vivo

Y. Yen, Yun-Ru Liu, S. Pan, 2016, Oncotarget.

Stellettin B Induces Cell Death in Bladder Cancer Via Activating the Autophagy/DAPK2/Apoptosis Signaling Cascade

J. Su, Tsung-Han Hsieh, Chun-Han Chen, 2023, Marine drugs.

Dual Inhibition of PIK3C3 and FGFR as a New Therapeutic Approach to Treat Bladder Cancer

Y. Yen, Cheng-Ying Chu, Tsung-Han Hsieh, 2017, Clinical Cancer Research.

TW01001, a novel piperazinedione compound, induces mitotic arrest and autophagy in non-small cell lung cancer A549 cells.

C. Teng, S. Pan, Yi-nan Liu, 2013, Cancer letters.

Novel mechanism by which histone deacetylase inhibitors facilitate topoisomerase IIα degradation in hepatocellular carcinoma cells

S. Kulp, C. Teng, H. Chuang, 2011, Hepatology.

N-alkyl-hydroxybenzoyl anilide hydroxamates as dual inhibitors of HDAC and HSP90, downregulating IFN-γ induced PD-L1 expression.

S. Pan, Samir Mehndiratta, Yi-Wen Wu, 2019, European journal of medicinal chemistry.

Isoindoline scaffold-based dual inhibitors of HDAC6 and HSP90 suppressing the growth of lung cancer in vitro and in vivo.

S. Pan, Han-Li Huang, J. Liou, 2020, European journal of medicinal chemistry.

Synthesis and evaluation of novel 7H-pyrrolo-[2,3-d]pyrimidine derivatives as potential anticancer agents.

T. Yeh, J. Liou, Yi-Min Liu, 2019, Future medicinal chemistry.

CK1δ as a potential therapeutic target to treat bladder cancer

Tsung-Han Hsieh, Yu-chen Lin, J. Liou, 2020, Aging.

1-Arylsulfonyl-5-(N-hydroxyacrylamide)tetrahydroquinolines as potent histone deacetylase inhibitors suppressing the growth of prostate cancer cells.

S. Pan, T. Yeh, J. Liou, 2015, European journal of medicinal chemistry.

MPT0G066, a novel anti-mitotic drug, induces JNK-independent mitotic arrest, JNK-mediated apoptosis, and potentiates antineoplastic effect of cisplatin in ovarian cancer

C. Teng, S. Pan, Han-Li Huang, 2016, Scientific Reports.

Molecular mechanisms underlying the antitumor activity of (E)-N-hydroxy-3-(1-(4-methoxyphenylsulfonyl)-1,2,3,4-tetrahydroquinolin-6-yl)acrylamide in human colorectal cancer cells in vitro and in vivo

C. Teng, S. Pan, Chia-Hwa Lee, 2015, Oncotarget.

Combining an Autophagy Inhibitor, MPT0L145, with Abemaciclib Is a New Therapeutic Strategy in GBM Treatment

Y. Yen, Tsung-Han Hsieh, Yu-chen Lin, 2021, Cancers.

The Novel Reductase Inhibitor COH29 Inhibits DNA Repair In Vitro.

M. C. Hu, Yate-Ching Yuan, Xiyong Liu, 2015 .

Inhibitor Inhibits DNA Repair Vitro.

Yate-Ching Yuan, Xiyong Liu, Bingsen Zhou, 2015 .

Inhibits DNA Repair

Yate-Ching Yuan, Xiyong Liu, Bingsen Zhou, 2015 .

Cucurbitacin E Exerts Anti-Proliferative Activity via Promoting p62-Dependent Apoptosis in Human Non-Small-Cell Lung Cancer A549 Cells

Chun-Han Chen, Nham-Linh Nguyen, Mei‐Chuan Chen, 2023, Current issues in molecular biology.